BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 17681396)

  • 1. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin-remodelling mechanisms in cancer.
    Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W
    Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic drivers and genetic passengers on the road to cancer.
    Sawan C; Vaissière T; Murr R; Herceg Z
    Mutat Res; 2008 Jul; 642(1-2):1-13. PubMed ID: 18471836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
    Reamon-Buettner SM; Borlak J
    Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome: a new target in cancer therapy.
    Giacinti L; Vici P; Lopez M
    Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylomes, histone codes and miRNAs: tying it all together.
    Guil S; Esteller M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mammalian epigenome.
    Bernstein BE; Meissner A; Lander ES
    Cell; 2007 Feb; 128(4):669-81. PubMed ID: 17320505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations and cancer: new targets for therapy.
    Allen A
    IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.